Progenitor cells from patients with MDS-derived AML display a mixed response to TGF-β, with AML cells in only four of seven cases escaping TGF-β mediated growth inhibition (Koschmieder et al. 2001). This evidence concerns the gene TGFB1 and acute myeloid leukemia.